Study population, determination

In Section 4D.2 we introduced two probability distributions commonly encountered when studying populations. The construction of confidence intervals for a normally distributed population was the subject of Section 4D.3. We have yet to address, however, how we can identify the probability distribution for a given population. In Examples 4.11-4.14 we assumed that the amount of aspirin in analgesic tablets is normally distributed. We are justified in asking how this can be determined without analyzing every member of the population. When we cannot study the whole population, or when we cannot predict the mathematical form of a population s probability distribution, we must deduce the distribution from a limited sampling of its members. 

The determination of the laser-generated populations rij t) is infinitely more delicate. Computer simulations can certainly be applied to study population relaxation times of different electronic states. However, such simulations are no longer completely classical. Semiclassical simulations have been invented for that purpose, and the methods such as surface hopping were proposed. Unfortunately, they have not yet been employed in the present context. Laser spectroscopic data are used instead the decay of the excited state populations is written n (t) = exp(—t/r ), where Xj is the experimentally determined population relaxation time. The laws of chemical kinetics may also be used when necessary. Proceeding in this way, the rapidly varying component of AS q, t) can be determined. 

Phase 1 trials are the first in man studies of a new drug in humans. These studies are usually carried out on small samples of subjects. The idea here is to determine the safety of the drug in a small and usually healthy volunteer study population. 

Concomitant or prior medications may be used in either safety or efficacy analyses. The presence of specific medications may be used as covariates for inferential analyses. Also, medications are often summarized to show that the therapies under study come from medically comparable populations. Medications may be used to determine protocol compliance and to help define a protocol-compliant study population. Concomitant medications may be examined to determine whether they interact with study therapy or whether they can explain the presence of certain adverse events. From a CDISC perspective, prior medications would be considered a finding while concomitant medications would be considered an intervention. 

The written informed consent form should be presented to potential participants in a language that they understand and written in terms that they can comprehend. This is one of the important functions of an IRB. The IRB members review every informed consent form to determine if it contains all of the required elements and any additional required elements of an informed consent form as sef forth in the governing regulations. The informed consent form is also reviewed to determine that complete, accurate, and pertinent study-related information is being provided to the potential participants and that medical terms are clearly defined, in simple language at the study population can understand. 

Significant ethnic variability is observed with many pharmacogenetic markers (38). Consequently, the demographics of the study population need to be taken into account when performing power analyses to determine the appropriate sample size. If the frequency of the polymorphism to be studied is unknown in any of the ethnic groups included in the study, the polymorphism should be screened in relevant population controls to determine their allele frequency. This will help to narrow down the number of polymorphisms to be included and prevent using finite patient DNA to assess markers that may have low frequency or be absent from the study population. 

This information may affect selection criteria for the study population and the choice of tests in addition to routine safety monitoring, and will certainly determine the starting dose, range of doses, maximum exposure and dose increments to be studied. Pharmacokinetics in man may be quite different from those in animal species so that plasma and, if possible, tissue concentrations are generally more important than dose. One exception to this may be hepatotox-icity resulting from exposure of the liver to portal blood drug concentrations, when the oral dose administered to the animals may be more relevant than the systemic plasma concentrations, which reflect first-pass metabolism as well as absorption. 

Limiting drug trials to short periods of time (often only several weeks). Drug companies rarely do longterm studies to determine how large populations experience medications over time. ... 

Consequently, a more objective way to measure the habitual intake of milk fat would be the fatty acid composition of adipose tissue. However, this is not routinely performed in larger cohort studies, due to cost and that the procedure is invasive and less tolerated by study participants. Analysis of plasma fatty acid composition is thus a more feasible option for examination to determine dairy intake in the study population. While some groups have separated plasma into its constituent phospholipids and cholesterol esters to analyze serum 15 0 and 17 0 as markers of dairy intake (Smedman et al., 1999), Baylin et al. (2005) found that plasma that was not separated into its constituent cholesteryl ester, phospholipids, and triacylglycerols was still able to reflect habitual dairy intakes comparably to adipose tissue. Thus, whole plasma is an acceptable alternative to fractionated plasma in the absence of adipose tissue for analysis to reflect habitual dairy intakes and may be a cost effective option for consideration when conducting future intervention studies to assess the affect of dairy products on health outcomes. 

The goal of the biological validation procedure depends on the nature of the process. If the process is intended to sterilize only, the probability of survival approach is used. In this case, validation studies must determine a dry-heat cycle that will assure that the probability of survival of the microbial indicator is not greater than 10 If the process is intended to sterilize and depyrogenate, which occurs when the materials can withstand excessive heat, the overkill approach is used. The goal here is to validate a heating cycle that can produce a 12-log reduction in the biological indicator population. 

Analytical measurements should be made with properly tested and documented procedures. These procedures should utilise controls and calibration steps to minimise random and systematic errors. There are basically two types of controls (a) those used to determine whether or not an analytical procedure is in statistical control, and (b) those used to determine whether or not an analyte of interest is present in a studied population but not in a similar control population. The purpose of calibration is to minimise bias in the measurement process. Calibration or standardisation critically depends upon the quality of the chemicals in the standard solutions and the care exercised in their preparation. Another important factor is the stability of these standards once they are prepared. Calibration check standards should be freshly prepared frequently, depending on their stability (Keith, 1991). No data should be reported beyond the range of calibration of the methodology. Appropriate quality control samples and experiments must be included to verify that interferences are not present with the analytes of interest, or, if they are, that they be removed or accommodated. 

Once exposures are identified and measured, it is necessary to determine how best to measure growth and development. If pregnant women comprise the study population, repeated fetal measurements will be needed at standardized intervals. Growth requires a... 

---